Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 2
2013 1
2014 4
2015 1
2016 1
2017 1
2018 1
2019 2
2021 2
2022 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Rapid and sustained B-cell depletion with subcutaneous ofatumumab in relapsing multiple sclerosis: APLIOS, a randomized phase-2 study.
Bar-Or A, Wiendl H, Montalban X, Alvarez E, Davydovskaya M, Delgado SR, Evdoshenko EP, Giedraitiene N, Gross-Paju K, Haldre S, Herrman CE, Izquierdo G, Karelis G, Leutmezer F, Mares M, Meca-Lallana JE, Mickeviciene D, Nicholas J, Robertson DS, Sazonov DV, Sharlin K, Sundaram B, Totolyan N, Vachova M, Valis M, Bagger M, Häring DA, Ludwig I, Willi R, Zalesak M, Su W, Merschhemke M, Fox EJ. Bar-Or A, et al. Among authors: sazonov dv. Mult Scler. 2022 May;28(6):910-924. doi: 10.1177/13524585211044479. Epub 2021 Oct 4. Mult Scler. 2022. PMID: 34605319 Free PMC article. Clinical Trial.
Confocal Laser Endomicroscopy in a Critically Ill COVID-19 Patient.
Danilevskaya O, Sazonov D, Klypa T, Zabozlaev F, Popova E. Danilevskaya O, et al. Among authors: sazonov d. Tuberc Respir Dis (Seoul). 2022 Jul;85(3):273-275. doi: 10.4046/trd.2022.0023. Epub 2022 Mar 23. Tuberc Respir Dis (Seoul). 2022. PMID: 35320666 Free PMC article. No abstract available.
Effect of ofatumumab versus placebo in relapsing multiple sclerosis patients from Japan and Russia: Phase 2 APOLITOS study.
Kira JI, Nakahara J, Sazonov DV, Kurosawa T, Tsumiyama I, Willi R, Zalesak M, Pingili R, Häring DA, Ramanathan K, Kieseier BC, Merschhemke M, Su W, Saida T. Kira JI, et al. Among authors: sazonov dv. Mult Scler. 2022 Jul;28(8):1229-1238. doi: 10.1177/13524585211055934. Epub 2021 Nov 17. Mult Scler. 2022. PMID: 34787005 Clinical Trial.
Is it actually a pCLE image of a sarcoid granuloma?
Danilevskaya OV, Sorokina AV, Averyanov AV, Sazonov DV, Zabozlaev FG. Danilevskaya OV, et al. Among authors: sazonov dv. Am J Respir Crit Care Med. 2014 Jan 15;189(2):235. doi: 10.1164/rccm.201307-1286LE. Am J Respir Crit Care Med. 2014. PMID: 24428659 No abstract available.
[A retrospective analysis of the effect of pregnancy on the course of multiple sclerosis].
Popova EV, Korobko DS, Bulatova EV, Melnikova AA, Babenko LA, Sazonov DS, Boyko AN, Malkova NA, Sivertseva SA, Gusev EI. Popova EV, et al. Among authors: sazonov ds. Zh Nevrol Psikhiatr Im S S Korsakova. 2015;115(8. Vyp. 2):18-21. doi: 10.17116/jnevro20151158218-21. Zh Nevrol Psikhiatr Im S S Korsakova. 2015. PMID: 28635710 Russian.
[Efficacy, tolerability and safety of the treatment with teberif: the results of a 2-year randomized clinical trial of treatment naïve patients with remitting multiple sclerosis, who have not received DMT, after switching from other interferon β-1a].
Boyko AN, Bosenko LP, Vasilovskiy VV, Volkova LI, Zakharova MN, Kotov SV, Lekomtseva EV, Negrich TI, Parshina EV, Patrusheva OP, Prokopenko SV, Sazonov DV, Timchenko LV, Trinitatskiy YV, Khabirov FA, Khavunka MY, Chichanovskaya LV, Sherman MA, Ivanov RA, Lin'kova YN, Stukalina EY, Zinkina-Orikhan AV, Obukhova IG. Boyko AN, et al. Among authors: sazonov dv. Zh Nevrol Psikhiatr Im S S Korsakova. 2019;119(2. Vyp. 2):73-85. doi: 10.17116/jnevro20191192273. Zh Nevrol Psikhiatr Im S S Korsakova. 2019. PMID: 31156245 Clinical Trial. Russian.
[The efficacy and safety of siponimod in the Russian population of patients with secondary progressive multiple sclerosis].
Evdoshenko EP, Neofidov NA, Bakhtiyarova KZ, Davydovskaya MV, Kairbekova EI, Kolontareva YM, Malkova NA, Odinak MM, Popova EV, Sazonov DV, Stolyarov ID, Smagina IV, Fedyanin AS, Habirov FA, Khaibullin TI, Khachanova NV, Shchukin IA, Boyko AN. Evdoshenko EP, et al. Among authors: sazonov dv. Zh Nevrol Psikhiatr Im S S Korsakova. 2019;119(10. Vyp. 2):110-119. doi: 10.17116/jnevro201911910110. Zh Nevrol Psikhiatr Im S S Korsakova. 2019. PMID: 31934996 Clinical Trial. Russian.
16 results